Roles of the epoxygenase CYP2J2 in the endothelium

Prostaglandins and Other Lipid Mediators

Volumn 107, Issue , 2013, Pages 56-63

  Askari, Ara ^a   Thomson, Scott J ^a   Edin, Matthew L ^b   Zeldin, Darryl C ^b   Bishop Bailey, David ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Angiogenesis; Dilation; Endothelial; Epoxygenase; Inflammation; Metabolism

Indexed keywords

ALBENDAZOLE; AMIODARONE; ANGIOTENSIN II; ARACHIDONIC ACID; ASTEMIZOLE; CAREBASTINE; CYCLOSPORIN; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2J2; DANAZOL; DOCOSAHEXAENOIC ACID; EBASTINE; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MESORIDAZINE; REACTIVE OXYGEN METABOLITE; TERFENADINE; THIORIDAZINE;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTITHROMBOTIC ACTIVITY; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CILIATED EPITHELIUM; CORONARY ARTERY DISEASE; DEPRESSED BLOOD PRESSURE; DRUG ACTIVITY; DRUG HYDROXYLATION; DRUG METABOLISM; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIUM CELL; HEART INFARCTION; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLITE; NEOINTIMA; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE; WOUND HEALING;

ANGIOGENESIS; DILATION; ENDOTHELIAL; EPOXYGENASE; INFLAMMATION; METABOLISM;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FATTY ACIDS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84889096477     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.02.003     Document Type: Review

References (96)

1. E. Gerlach, S. Nees, and B.F. Becker The vascular endothelium: a survey of some newly evolving biochemical and physiological features Basic Res Cardiol 80 5 1985 459 474 (Pubitemid 16244319)
2. T. Hla, and K. Neilson Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 89 16 1992 7384 7388
3. S. Moncada, R. Gryglewski, S. Bunting, and J.R. Vane An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 5579 1976 663 665
4. D. Bishop-Bailey, J.A. Mitchell, and T.D. Warner COX-2 in cardiovascular disease Arterioscler Thromb Vasc Biol 26 5 2006 956 958 (Pubitemid 43732096)
5. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 39 2001 36059 36062
6. M. Spiecker, and J.K. Liao Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids Arch Biochem Biophys 433 2 2005 413 420 (Pubitemid 39592795)
7. J. Capdevila, N. Chacos, J. Werringloer, R.A. Prough, and R.W. Estabrook Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid Proc Natl Acad Sci USA 78 9 1981 5362 5366 (Pubitemid 12248586)
8. B.E. Daikh, J.M. Lasker, J.L. Raucy, and D.R. Koop Regio-and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9 J Pharmacol Exp Ther 271 3 1994 1427 1433 (Pubitemid 24382654)
9. D.R. Nelson, D.C. Zeldin, S.M. Hoffman, L.J. Maltais, H.M. Wain, and D.W. Nebert Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants Pharmacogenetics 14 1 2004 1 18 (Pubitemid 38183957)
10. K. Stark, M. Dostalek, and F.P. Guengerich Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide FEBS J 275 14 2008 3706 3717
11. J.H. Capdevila, A. Karara, D.J. Waxman, M.V. Martin, J.R. Falck, and F.P. Guenguerich Cytochrome P-450 enzyme-specific control of the regio-and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase J Biol Chem 265 19 1990 10865 10871
12. D.S. Keeney, C. Skinner, S. Wei, T. Friedberg, and M.R. Waterman A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid J Biol Chem 273 15 1998 9279 9284 (Pubitemid 28176221)
13. C.M. Thompson, J.H. Capdevila, and H.W. Strobel Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid J Pharmacol Exp Ther 294 3 2000 1120 1130 (Pubitemid 30666868)
14. M.F. Oleksiak, S. Wu, C. Parker, S.I. Karchner, J.J. Stegeman, and D.C. Zeldin Identification, functional characterization, and regulation of a new cytochrome P450 subfamily, the CYP2Ns J Biol Chem 275 4 2000 2312 2321 (Pubitemid 30081987)
15. A.B. Rifkind, C. Lee, T.K. Chang, and D.J. Waxman Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes Arch Biochem Biophys 320 2 1995 380 389
16. R. Mitra, Z. Guo, and M. Milani CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14,15-epoxyeicosatrienoic acid (EET) J Biol Chem 286 20 2011 17543 17559
17. I. Fleming, U.R. Michaelis, and D. Bredenkotter Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries Circ Res 88 1 2001 44 51 (Pubitemid 32064081)
18. S. Wu, C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 7 1996 3460 3468 (Pubitemid 26065653)
19. D.C. Zeldin, J. Foley, and J. Ma CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance Mol Pharmacol 50 5 1996 1111 1117 (Pubitemid 26384849)
20. K. Node, Y. Huo, and X. Ruan Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 5431 1999 1276 1279 (Pubitemid 29398616)
21. T.C. Delozier, G.E. Kissling, and S.J. Coulter Detection of human CYP2C8 CYP2C9, and CYP2J2 in cardiovascular tissues Drug Metab Dispos 35 4 2007 682 688 (Pubitemid 46513273)
22. C. Bertrand-Thiebault, L. Ferrari, and O. Boutherin-Falson Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis Clin Exp Pharmacol Physiol 31 5-6 2004 295 301 (Pubitemid 38803071)
23. J. Bystrom, J.A. Wray, and M.C. Sugden Endogenous epoxygenases are modulators of monocyte/macrophage activity PLoS ONE 6 10 2011 e26591
24. A. Gaedigk, D.W. Baker, and R.A. Totah Variability of CYP2J2 expression in human fetal tissues J Pharmacol Exp Ther 319 2 2006 523 532
25. D.R. Nelson The cytochrome p450 homepage Hum Genomics 4 1 2009 59 65
26. C. Westphal, A. Konkel, and W.H. Schunck CYP-eicosanoids-a new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat 96 1-4 2013 99 108
27. K. Nakayama, T. Nitto, T. Inoue, and K. Node Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes Life Sci 83 9-10 2008 339 345
28. B.T. Larsen, H. Miura, and O.A. Hatoum Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition Am J Physiol Heart Circ Physiol 290 2 2006 H491 H499
29. S. Kundu, T. Roome, and A. Bhattacharjee Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo J Lipid Res 54 2 2013 436 447
30. D. Zhang, X. Xie, Y. Chen, B.D. Hammock, W. Kong, and Y. Zhu Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo Circ Res 110 6 2013 808 817
31. M. Revermann, M. Schloss, and E. Barbosa-Sicard Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice Arterioscler Thromb Vasc Biol 30 5 2013 909 914
32. C.R. Lee, J.D. Imig, and M.L. Edin Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice FASEB J 24 10 2013 3770 3781
33. C.A. Lee, D. Neul, and A. Clouser-Roche Identification of novel substrates for human cytochrome P450 2J2 Drug Metab Dispos 38 2 2013 347 356
34. S. Ren, J. Zeng, and Y. Mei Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors Drug Metab Dispos 41 1 2013 60 71
35. P. Lafite, S. Dijols, and D. Buisson Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2 Bioorg Med Chem Lett 16 10 2006 2777 2780
36. P. Lafite, S. Dijols, D.C. Zeldin, P.M. Dansette, and D. Mansuy Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2 Arch Biochem Biophys 464 2 2007 155 168 (Pubitemid 47210920)
37. B. Yang, L. Graham, and S. Dikalov Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells Mol Pharmacol 60 2 2001 310 320 (Pubitemid 32678296)
38. J. Seubert, B. Yang, and J.A. Bradbury Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway Circ Res 95 5 2004 506 514 (Pubitemid 39180931)
39. M.L. Edin, Z. Wang, and J.A. Bradbury Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart FASEB J 25 10 2012 3436 3447
40. R. Li, X. Xu, and C. Chen Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice Prostaglandins Other Lipid Mediat 99 3-4 2013 68 78
41. G. Zhao, L. Tu, and X. Li Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis Hum Gene Ther 23 7 2012 688 699
42. Y. Deng, M.L. Edin, and K.N. Theken Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice FASEB J 25 2 2011 703 713
43. A. Oni-Orisan, Y. Deng, and R.N. Schuck Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice Prostaglandins Other Lipid Mediat 2012
44. J. Sun, X. Sui, J.A. Bradbury, D.C. Zeldin, M.S. Conte, and J.K. Liao Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids Circ Res 90 9 2002 1020 1027 (Pubitemid 34633869)
45. K.S. Moshal, D.C. Zeldin, and S.D. Sithu Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia J Cell Physiol 215 3 2008 771 781 (Pubitemid 351632699)
46. J.D. Imig Epoxides and soluble epoxide hydrolase in cardiovascular physiology Physiol Rev 92 1 2012 101 130
47. D. Panigrahy, E.R. Greene, A. Pozzi, D.W. Wang, and D.C. Zeldin EET signaling in cancer Cancer Metastasis Rev 30 3-4 2011 525 540
48. A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 Suppl. 2009 S52 S56
49. I. Fleming The cytochrome P450 pathway in angiogenesis and endothelial cell biology Cancer Metastasis Rev 30 3-4 2011 541 555
50. M. Potente, B. Fisslthaler, R. Busse, and I. Fleming 11,12- Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1 J Biol Chem 278 32 2003 29619 29625 (Pubitemid 36962345)
51. U.R. Michaelis, B. Fisslthaler, M. Medhora, D. Harder, I. Fleming, and R. Busse Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR) FASEB J 17 6 2003 770 772
52. B. Zhang, H. Cao, and G.N. Rao Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15- epoxyeicosatrienoic acid-induced angiogenesis J Biol Chem 281 2 2006 905 914
53. S.Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R.C. Venema, and G.N. Rao An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis Blood 111 12 2008 5581 5591
54. G. Yan, S. Chen, B. You, and J. Sun Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids Cardiovasc Res 78 2 2008 308 314 (Pubitemid 351556100)
55. Y. Wang, X. Wei, and X. Xiao Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways J Pharmacol Exp Ther 314 2 2005 522 532 (Pubitemid 41043832)
56. D. Panigrahy, M.L. Edin, and C.R. Lee Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice J Clin Invest 122 1 2012 178 191
57. J.G. Jiang, Y.G. Ning, and C. Chen Cytochrome p450 epoxygenase promotes human cancer metastasis Cancer Res 67 14 2007 6665 6674 (Pubitemid 47105512)
58. A.A. Elmarakby Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease Am J Physiol Regul Integr Comp Physiol 302 3 2013 R321 R330
59. W.K. Lin, J.R. Falck, and P.Y. Wong Effect of 14,15-epoxyeicosatrienoic acid infusion on blood pressure in normal and hypertensive rats Biochem Biophys Res Commun 167 3 1990 977 981 (Pubitemid 20113277)
60. Z. Yu, L.M. Huse, and P. Adler Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney Mol Pharmacol 57 5 2000 1011 1020 (Pubitemid 30253386)
61. M.A. Nayeem, D.C. Zeldin, and M.A. Boegehold Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase Am J Physiol Regul Integr Comp Physiol 299 1 2013 R325 R333
62. J.G. Jiang, R.J. Chen, and B. Xiao Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids Prostaglandins Other Lipid Mediat 82 1-4 2007 162 174 (Pubitemid 44895441)
63. B. Xiao, X. Li, and J. Yan Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide J Pharmacol Exp Ther 334 3 2010 784 794
64. F. Herse, B. Lamarca, and C.A. Hubel CYP2J2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia Circulation 126 25 2012 2990 2999
65. C. Zheng, L. Wang, and R. Li Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats Am J Respir Cell Mol Biol 43 6 2013 740 749
66. B. Keseru, E. Barbosa-Sicard, and R. Popp Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response FASEB J 22 12 2008 4306 4315
67. B. Keseru, E. Barbosa-Sicard, and R.T. Schermuly Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition Cardiovasc Res 85 1 2010 232 240
68. A.E. Loot, and I. Fleming Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels J Cardiovasc Pharmacol 57 2 2013 140 147
69. A.E. Loot, I. Moneke, and B. Keseru 11,12-EET stimulates the association of BK channel alpha and beta(1) subunits in mitochondria to induce pulmonary vasoconstriction PLoS ONE 7 9 2013 e46065
70. P. Pokreisz, I. Fleming, and L. Kiss Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling Hypertension 47 4 2006 762 770 (Pubitemid 43740249)
71. K. Node, X.L. Ruan, and J. Dai Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids J Biol Chem 276 19 2001 15983 15989
72. F.A. Fitzpatrick, M.D. Ennis, M.E. Baze, M.A. Wynalda, J.E. McGee, and W.F. Liggett Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry J Biol Chem 261 32 1986 15334 15338 (Pubitemid 17218115)
73. F. Krotz, T. Riexinger, and M.A. Buerkle Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids Arterioscler Thromb Vasc Biol 24 3 2004 595 600 (Pubitemid 38326158)
74. L. Zhang, Y. Cui, B. Geng, X. Zeng, and C. Tang 11,12-Epoxyeicosatrienoic acid activates the l-arginine/nitric oxide pathway in human platelets Mol Cell Biochem 308 1-2 2008 51 56 (Pubitemid 351167844)
75. K.E. Swales, and D. Bishop-Bailey The potential use of the pregnane X receptor in cardiovascular therapy Expert Rev Cardiovasc Ther 10 9 2013 1079 1082
76. K.E. Swales, R. Moore, and N.J. Truss Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress Cardiovasc Res 93 4 2012 674 681
77. K.H. Liu, M.G. Kim, and D.J. Lee Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A Drug Metab Dispos 34 11 2006 1793 1797
78. C.A. Lee, J.P. Jones 3rd, and J. Katayama Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity Drug Metab Dispos 40 5 2012 943 951
79. V. Michaud, M. Frappier, M.C. Dumas, and J. Turgeon Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism PLoS ONE 5 12 2013 e15666
80. J. Borlak, M. Walles, K. Levsen, and T. Thum Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells Drug Metab Dispos 31 7 2003 888 891 (Pubitemid 36759058)
81. I. Aiba, T. Yamasaki, and T. Shinki Characterization of rat and human CYP2J enzymes as vitamin D 25-hydroxylases Steroids 71 10 2006 849 856 (Pubitemid 44286955)
82. Y. Minamiyama, S. Takemura, S. Imaoka, Y. Funae, and S. Okada Cytochrome P450 is responsible for nitric oxide generation from NO-aspirin and other organic nitrates Drug Metab Pharmacokinet 22 1 2007 15 19
83. S.S. Lee, H.E. Jeong, and K.H. Liu Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity Pharmacogenet Genomics 15 2 2005 105 113 (Pubitemid 40562987)
84. J. Ma, S. Ramachandran, F.T. Fiedorek Jr., and D.C. Zeldin Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4 Genomics 49 1 1998 152 155 (Pubitemid 28194450)
85. L.M. King, J. Ma, and S. Srettabunjong Cloning of CYP2J2 gene and identification of functional polymorphisms Mol Pharmacol 61 4 2002 840 852 (Pubitemid 34273164)
86. M. Spiecker, H. Darius, and T. Hankeln Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Circulation 110 15 2004 2132 2136 (Pubitemid 39372490)
87. J. Borgel, D. Bulut, and C. Hanefeld The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile BMC Cardiovasc Disord 8 2008 41
88. K.D. Marciante, R.A. Totah, and S.R. Heckbert Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke Pharmacogenet Genomics 18 6 2008 535 543 (Pubitemid 351769921)
89. C.R. Lee, K.E. North, M.S. Bray, D.J. Couper, G. Heiss, and D.C. Zeldin CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study Pharmacogenet Genomics 17 5 2007 349 358 (Pubitemid 46608542)
90. Y. Xu, H. Ding, and J. Peng Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease Pharmacogenet Genomics 21 8 2013 489 494
91. A.V. Polonikov, V.P. Ivanov, and M.A. Solodilova A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population Dis Markers 24 2 2008 119 126
92. S.N. Wu, Y. Zhang, and C.O. Gardner Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension Ann Hum Genet 71 2007 519 525 Pt 4 (Pubitemid 46865499)
93. A. Alghasham, A. Ali, H. Ismail, M. Dowaidar, and A.A. Settin CYP2J2-50 G/T and ADRB2 G46A gene polymorphisms in Saudi subjects with hypertension Genet Test Mol Biomarkers 16 9 2013 1027 1031
94. C. Fava, M. Montagnana, and P. Almgren The common functional polymorphism-50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes J Hypertens 28 2 2010 294 299
95. L.M. King, J.V. Gainer, and G.L. David Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension Pharmacogenet Genomics 15 1 2005 7 13 (Pubitemid 43205521)
96. S.J. Thomson, A. Askari, and D. Bishop-Bailey Anti-inflammatory effects of epoxyeicosatrienoic acids Int J Vasc Med 2012 605101